Alopecia Areata-Like Presentations With Mogamulizumab Therapy
September 2023
in “
JAAD case reports
”
New to Alopecia Areata? There is a guide in the encyclopedia. Read the guide →
Studysummary In this case report, mogamulizumab treatment for Sézary syndrome was associated with rashes and alopecia in a patient, highlighting the potential for immune-mediated side effects and suggesting that such adverse effects might indicate a favorable prognosis, though further studies are needed.
Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer